United States — Food and Drug Administration & Erica Schwartz

United States — Food and Drug Administration: Responsible for approving any new separate vaccines, a process that could take years. It faces pressure to review unbundled shots without precedent.

Erica Schwartz: Newly confirmed CDC director, placed in an untenable position by the order, which may override her authority. Her response will be closely watched.

United States — Food and Drug Administration: The FDA led the investigation, linking the outbreak to Taylor Farms lettuce. It faced criticism for a false-positive test result and for potential influence by the United States — White House, but it continues to work on the investigation.

Erica Schwartz: CDC director nominee Erica Schwartz said she was unaware of the surveillance cuts, raising questions about her knowledge of the agency's operations.

United States — Food and Drug Administration: The FDA is mentioned as another agency with a leadership vacancy, but it is not directly involved in this event.

Erica Schwartz: Confirmed as CDC director, she is now responsible for leading the agency through a period of turmoil and rebuilding public trust. Her leadership is expected to bring stability, though her independence from political pressure remains uncertain.

United States — Food and Drug Administration: The FDA is the agency being led. It faces staff losses, morale issues, and policy controversies; Overton's nomination could exacerbate these challenges.

Erica Schwartz: Schwartz was confirmed as CDC director, part of broader health leadership changes. Not directly affected.

United States — Food and Drug Administration: The United States — Food and Drug Administration (FDA) is the regulatory body responsible for approving the mFlusiva vaccine. Its advisory committee's unanimous recommendation is a crucial step towards the vaccine's market entry, despite internal disputes and leadership vacancies.

Erica Schwartz: Erica Schwartz is President Trump's nominee for the next United States — Centers for Disease Control and Prevention director, whose Senate hearing has not yet been scheduled, contributing to the uncertainty surrounding the CDC's next steps.

Erica Schwartz: Erica Schwartz, a former deputy surgeon general, was nominated by Donald Trump to be the next United States — Centers for Disease Control and Prevention director, awaiting Senate confirmation.